Angiotensin receptor-neprilysin inhibition in patients with de novo acute decompensated heart failure: a prespecified subgroup analysis of the PIONEER-HF trial
1 September 2019 (08:48 - 09:06)
Organised by:
About the speaker
Kaiser Permanente, San Francisco Medical Centre and Medical Offices, San Francisco (United States of America)
4 More presentations in this session
Access the full session
The Event
ESC Congress 2019
1 September 2019
08:48 CET
You may be interested in
Congress Presentation
